The Shigella vaccine protects against a type of bacteria called Shigella. This bacterium is found in the throat and intestinal tract of healthy humans. The illness occurs only when infected feces reach the deeper levels of the small intestines, where they are broken down into their constituent parts. Shigella vaccines are able to protect against healthy individuals as well as against children and the elderly. In Japan, around 600 cases of shigellosis are confirmed each year and thus, shigella vaccines have become significantly important.
The Shigella vaccines prevent illnesses caused by bacteria called Shigella. These bacteria are transmitted to humans through direct contact with infectious secretions of Shigella bacteria. This type of illness is generally not serious. Children, pregnant women, and other people who have weak immune systems are at risk of contracting Shigella. The most common symptom of this illness is a red rash that spreads across the surface of the skin usually in the abdomen, groin area, or thighs. There is generally no pain, but the rash may cause itching or discomfort. Recently, in November 2020, Intravacc, a Dutch CDMO organization, released positive phase I Shigella conjugate vaccine data... Read more